TruScreen Group Limited (NZE:TRU)

Market Cap	14.20M -14.7%
Revenue (ttm)	2.83M +36.4%
Net Income	-2.25M
EPS	-0.00
Shares Out	747.33M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,156,571
Open	0.0180
Previous Close	0.0180
Day's Range	0.0180 - 0.0200
52-Week Range	0.0150 - 0.0260
Beta	-0.04
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 26, 2026

About TruScreen Group

TruScreen Group Limited, together with its subsidiaries, develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, and the Middle East/North Africa. It offers the TruScreen cervical cancer screening device, a medical device for identifying and detecting the presence of precancerous and cancerous tissue on the cervix in real time. The company was formerly known as TruScreen Limited and changed its name to Truscreen Group Limited in August 2020. TruScreen Group Limited was incorporated in...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2013
• Country: New Zealand
• Stock Exchange: New Zealand Stock Exchange
• Ticker Symbol: TRU

Financial Performance

In fiscal year 2026, TruScreen Group's revenue was 2.83 million, an increase of 36.38% compared to the previous year's 2.07 million. Losses were -2.25 million, 0.41% more than in 2025.